Talampanel for Amyotrophic Lateral Sclerosis

Study Title

Talampanel for Amyotrophic Lateral Sclerosis (ALS)

Teva Identifier

ALS-TAL-201 (ALSTAR) | ALSTAR

ClinicalTrials.gov Identifier

NCT00696332

Study Status

Completed

Trial Condition(s)

ALS

Interventions

Drug: Talampanel | Other: placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 80 Years

Trial Duration

09/01/2008 - 05/01/2010

Phase

Phase 2

Study Type

Interventional